Results include outcomes for 200+ shoulders and show exceptionally high patient satisfaction scores in a wide age range of patients.

The next-gen power tool aims to reduce physical burden on surgeons compared to manual impaction during primary and revision hip and revision knee replacement procedures.

Data from this first-in-human trial supports a strong safety profile for the VCFix system for the treatment of vertebral compression fractures.

Moximed’s MOTION RCT prospective, multicenter study compares the benefits in subjects with medial knee OA who are treated with either the MISHA Knee or non-surgical treatment.

OsteoFactor Pro is a blend of allogeneic growth factors engineered to improve bone healing and support surgical success across orthopedic and spine procedures.

The Y-STRUT is part of the company’s STRUTPLASTY technology to reinforce bones weakened by osteoporosis or cancer.

A major update introduces features to enhance surgical precision and streamline the planning process for shoulder replacement surgeries.

MSKai assists in the evaluation of previously acquired T2-weighted lumbar spine MRIs, performing measurement and export of results into customizable reports.

NEXXT MATRIXX SI leverages 3D-printed manufacturing technology to create this complementary offering for SI joint fusion procedures.

The company reports confirmation of studies for MOTYS regenerative biologic, designed as an intra-articular injection for the management of symptomatic knee OA.